Many different heritable connective tissue disorders (HCTD) have been described over the past decades. These syndromes often affect the connective tissue of various organ systems, including heart, blo...

YouTube video by acapellascience

Skype a Scientist matches your classroom, scout troop, or library with scientists for Q&A sessions for free!

The release processes of small extracellular vesicles (sEVs) remain poorly understood despite their importance. Here, Kunitake et al. present a screening platform called CIBER screening that enables e...

The FDA has cleared HuidaGene Therapeutics' investigational new drug application for HG202, the first CRISPR-Cas13 RNA-editing therapy to enter clinical trials. HG202 is designed to treat neovascular age-related macular degeneration, which is a leading cause of blindness in people over the age of 60.

It acts as a sort of molecular fumigator to battle phages and plasmids.

Skype a Scientist matches your classroom, scout troop, or library with scientists for Q&A sessions for free!

“For much of my scientific training I feared I was behind my peers,” this grad student writes

A clustering algorithm, FLSHclust, was developed and applied to discover 188 previously unreported CRISPR-linked gene modules.

Highlights, press releases and speeches

We revealed that the RNA-targeting activity of the Cas13 family of nucleases allows them to directly target endogenous RNA in mammalian cells. Such activity limits the usage of lentiviral Cas13 system...

The emergence of SARS-CoV-2, the causative agent of COVID-19, has resulted in the largest pandemic in recent history. Current therapeutic strategies to mitigate this disease have focused on the develo...

A prokaryotic RNA–directed targeting system can be designed to cleave any DNA sequence.

Transcription factors containing disordered regions can now be mapped across the genome, aiding functional studies.